[go: up one dir, main page]

AR098747A1 - Formas polimórficas de un compuesto similar a esteroides y métodos para su preparación y uso - Google Patents

Formas polimórficas de un compuesto similar a esteroides y métodos para su preparación y uso

Info

Publication number
AR098747A1
AR098747A1 ARP140104647A ARP140104647A AR098747A1 AR 098747 A1 AR098747 A1 AR 098747A1 AR P140104647 A ARP140104647 A AR P140104647A AR P140104647 A ARP140104647 A AR P140104647A AR 098747 A1 AR098747 A1 AR 098747A1
Authority
AR
Argentina
Prior art keywords
preparation
methods
polymorphic forms
similar compound
steroid
Prior art date
Application number
ARP140104647A
Other languages
English (en)
Inventor
Feng Shaoxin
W Smith Scott
M G Lambert Olivier
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52293229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR098747(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AR098747A1 publication Critical patent/AR098747A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los compuestos son útiles como medicamentos para el tratamiento de glaucoma, enfermedad del ojo seco e hipertensión ocular. Reivindicación 1: Una forma cristalina de un compuesto similar a un esteroide caracterizada por la fórmula (1). Reivindicación 2: La forma cristalina de la reivindicación 1, caracterizada porque tiene un patrón de difracción de rayos X con picos de alrededor de 7,4, 10,2, 11,4, 12,4, 14,3, 14,7, 17,4, 20,2, 22,4 y 31,6 grados 2q.
ARP140104647A 2013-12-13 2014-12-12 Formas polimórficas de un compuesto similar a esteroides y métodos para su preparación y uso AR098747A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361915589P 2013-12-13 2013-12-13

Publications (1)

Publication Number Publication Date
AR098747A1 true AR098747A1 (es) 2016-06-08

Family

ID=52293229

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140104647A AR098747A1 (es) 2013-12-13 2014-12-12 Formas polimórficas de un compuesto similar a esteroides y métodos para su preparación y uso

Country Status (17)

Country Link
US (1) US10065984B2 (es)
EP (1) EP3080140A2 (es)
JP (1) JP2016540001A (es)
KR (1) KR20160098338A (es)
CN (1) CN105814071A (es)
AR (1) AR098747A1 (es)
AU (1) AU2014361790B2 (es)
CA (1) CA2933371A1 (es)
CL (1) CL2016001429A1 (es)
IL (1) IL246059A0 (es)
MX (1) MX371012B (es)
PH (1) PH12016501098A1 (es)
SA (1) SA516371308B1 (es)
SG (2) SG10201709987QA (es)
TW (1) TWI659041B (es)
UA (1) UA121203C2 (es)
WO (1) WO2015089471A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019055028A1 (en) * 2017-09-15 2019-03-21 Kala Pharmaceuticals, Inc. PARTICLES, COMPOSITIONS AND METHODS FOR OPHTHALMIC APPLICATIONS AND / OR OTHER APPLICATIONS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6605514A (es) * 1966-04-25 1967-10-26
IT1056711B (it) * 1967-04-01 1982-02-20 Vismara F Spa Derivati dell idrocortisone
JPS52136157A (en) * 1976-04-14 1977-11-14 Taisho Pharmaceut Co Ltd Preparation of steroid 17-esters
JPS54151958A (en) * 1978-05-19 1979-11-29 Taisho Pharmaceut Co Ltd Preparation of pregnane steroid 17alpha-ester
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
CN103180321A (zh) * 2010-09-23 2013-06-26 Abbvie公司 氮杂金刚烷衍生物的一水合物
UA111867C2 (uk) * 2011-11-11 2016-06-24 Аллерган, Інк. ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ І СПОСІБ ЗАСТОСУВАННЯ ПОХІДНИХ 4-ПРЕГНЕН-11β-17-21-ТРІОЛ-3,20-ДІОНУ
EP2855458B1 (en) * 2012-05-11 2018-08-08 Reset Therapeutics, Inc. Carbazole-containing sulfonamides as cryptochrome modulators

Also Published As

Publication number Publication date
SG11201604786QA (en) 2016-07-28
MX2016007718A (es) 2016-09-09
WO2015089471A2 (en) 2015-06-18
EP3080140A2 (en) 2016-10-19
AU2014361790B2 (en) 2019-05-23
TW201609788A (zh) 2016-03-16
US20150166597A1 (en) 2015-06-18
JP2016540001A (ja) 2016-12-22
SA516371308B1 (ar) 2019-07-08
PH12016501098A1 (en) 2016-08-15
TWI659041B (zh) 2019-05-11
UA121203C2 (uk) 2020-04-27
MX371012B (es) 2020-01-10
CN105814071A (zh) 2016-07-27
US10065984B2 (en) 2018-09-04
KR20160098338A (ko) 2016-08-18
IL246059A0 (en) 2016-07-31
CL2016001429A1 (es) 2016-12-23
SG10201709987QA (en) 2018-01-30
WO2015089471A3 (en) 2015-11-19
AU2014361790A1 (en) 2016-07-07
CA2933371A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
CL2017003404A1 (es) Compuestos antibacterianos
MX2020011449A (es) Oxiesteroles y metodos de uso de los mismos.
MX2022012313A (es) Oxisteroles y metodos de uso de los mismos.
ECSP16000724A (es) Carboxamidas de anillo de 4 miembros empleadas como nematicidas
CR20160032A (es) Compuestos de pirimidinodiona contra estados cardíacos
CR20150472A (es) USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRANSTORNOS RELACIONADOS CON LA PI3Kd
EA201691194A1 (ru) Стимуляторы ргц
CU20170087A7 (es) Formas cristalinas de 5-(4-ciclopropil-1 h-imidazol-1-il)-n-(6-(4-isopropil-4h-1 , 2, 4- triazol-3-il)piridin-2-il)-2-fluoro-4-metilbenzamida
UY35916A (es) Compuestos tricíclicos como agentes antineoplásicos inhibidores del bromodominio
MX2018000280A (es) Oxiesteroles y metodos de uso de los mismos.
DOP2016000140A (es) Inhibidores de syk
CR20160523A (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer
UY36544A (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
CL2017001661A1 (es) Compuestos biciclicos fusionados para el tratamiento de una enfermedad.
CL2017000820A1 (es) Compuestos de aminopurina sustituida, composiciones de los mismos, y metodos de tratamiento con los mismos
CR20150378A (es) Compuestos tetracíclicos sustituidos con heterociclo y métodos de uso de los mismos para el tratamiento de enfermedades víricas
AR086586A1 (es) Forma cristalina de ciclosporina a, metodos de preparacion y metodos para utilizar la misma
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
CO2018007278A2 (es) Derivados de ácido aminobenzoico metaazacíclico como antagonistas de la integrina pan
CO6970598A2 (es) Derivados de 4-pregenen-11ss-17-21-triol-3,20-diona para el tratamiento de afecciones oculares
CL2016001756A1 (es) Preparación farmacéutica que comprende 0,001-0,003 pv de 6-4-pirazol-1-ilbencilpiridin-3-ilsulfonilaminometilpiridin-2-ilaminoacetato de isopropilo o una sal del mismo uso para el tratamiento o prevención de glaucoma o hipertensión ocular.
UY36677A (es) Compuestos tricíclicos como agentes antineoplásicos
NI201700052A (es) Diamino-quinoleína 2,4 sustituida como nuevos agentes anticancerígenos

Legal Events

Date Code Title Description
FB Suspension of granting procedure